Chris Opoku Fofie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Chris Opoku Fofie has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Adeline Adwoa Boatin
Department of Obstetrics and Gynecology Massachusetts General Hospital, Harvard Medical School Boston Massachusetts USA
2 shared publications - Afra Jiwa
Program for Global Surgery and Social Change, Harvard Medical School, Boston, MA, United States
2 shared publications - Antony Ngatia
Statsspeak Analytics, Nairobi, Kenya
2 shared publications - Bethany Hedt-Gauthier
Program in Global Surgery and Social Change, Harvard Medical School, Boston, MA, United States
2 shared publications - Christine M. O'BRien
Department of Biomedical Engineering, Washington University in St. Louis, St Louis, MO, United States
2 shared publications - Karim Benali
Global Health and Service Advisory Council, Harvard Medical School, Boston, MA, United States
2 shared publications
Latest Publications
- Top Cited PapersOpen Access
- 14 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e63495
Africa’s Digital Health Revolution: The Digital Fit-Viability Model to Move From Innovation to Scaled Implementation
Digital innovations hold immense potential to transform health care delivery, particularly in sub-Saharan Africa, where financial, geographical, and infrastructural constraints continue to hinder progress toward universal health care delivery. Although a growing health tech sector offers creative solutions, few digital health interventions reach scaled implementation. In this paper, we present the digital fit/viability model—an adapted determinant framework to describe facilitators and barriers to moving from digital tools to integrated digital health implementation. We then use this model to describe the specific challenges and recommended solutions when developing digital health tools for health systems in sub-Saharan Africa.
- 14 January 2026
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 28, e63495
Top Cited PapersOpen AccessAfrica’s Digital Health Revolution: The Digital Fit-Viability Model to Move From Innovation to Scaled Implementation
Digital innovations hold immense potential to transform health care delivery, particularly in sub-Saharan Africa, where financial, geographical, and infrastructural constraints continue to hinder progress toward universal health care delivery. Although a growing health tech sector offers creative solutions, few digital health interventions reach scaled implementation. In this paper, we present the digital fit/viability model—an adapted determinant framework to describe facilitators and barriers to moving from digital tools to integrated digital health implementation. We then use this model to describe the specific challenges and recommended solutions when developing digital health tools for health systems in sub-Saharan Africa.
- Open Access
- 24 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Africa’s Digital Health Revolution: The Digital Fit-Viability Model to Move From Innovation to Scaled Implementation (Preprint)
UNSTRUCTURED Digital innovations hold immense potential to transform health care delivery, particularly in sub-Saharan Africa, where financial, geographical, and infrastructural constraints continue to hinder progress toward universal health care delivery. Although a growing health tech sector offers creative solutions, few digital health interventions reach scaled implementation. In this paper, we present the digital fit/viability model—an adapted determinant framework to describe facilitators and barriers to moving from digital tools to integrated digital health implementation. We then use this model to describe the specific challenges and recommended solutions when developing digital health tools for health systems in sub-Saharan Africa.
- 24 June 2024
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAfrica’s Digital Health Revolution: The Digital Fit-Viability Model to Move From Innovation to Scaled Implementation (Preprint)
UNSTRUCTURED Digital innovations hold immense potential to transform health care delivery, particularly in sub-Saharan Africa, where financial, geographical, and infrastructural constraints continue to hinder progress toward universal health care delivery. Although a growing health tech sector offers creative solutions, few digital health interventions reach scaled implementation. In this paper, we present the digital fit/viability model—an adapted determinant framework to describe facilitators and barriers to moving from digital tools to integrated digital health implementation. We then use this model to describe the specific challenges and recommended solutions when developing digital health tools for health systems in sub-Saharan Africa.
- Open Access
- 20 June 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (6) , e0003181
Modeling the economic burden of postpartum hemorrhage due to substandard uterotonics in Ghana
Uterotonics are essential in preventing postpartum hemorrhage (PPH), the leading direct cause of maternal death worldwide. However, uterotonics are often substandard in low- and middle-income countries, contributing to poor maternal health outcomes. This study examines the health and economic impact of substandard uterotonics in Ghana. A decision-tree model was built to simulate vaginal and cesarean section births across health facilities, uterotonic quality and utilization, PPH risk and diagnosis, and resulting health and economic outcomes. We utilized delivery data from Ghana’s maternal health survey, risks of health outcomes from a Cochrane review, and E-MOTIVE trial data for health outcomes related to oxytocin quality. We compared scenarios with and without substandard uterotonics, as well as scenarios altering uterotonic use and care-seeking behaviors. We found that substandard uterotonic use contributes to $18.8 million in economic burden annually, including $6.3 million and $4.8 million in out-of-pocket expenditures in public and private sectors, respectively. Annually, the National Health Insurance Scheme bears $1.6 million in costs due to substandard uterotonic use. Substandard uterotonics contribute to $6 million in long-term productivity losses from maternal mortality annually. Improving the quality of uterotonics could reduce 20,000 (11%) PPH cases, 5,000 (11%) severe PPH cases, and 100 (11%) deaths due to PPH annually in Ghana. Ensuring the quality of uterotonics would result in millions of dollars in cost savings and improve maternal health outcomes for the government and families in Ghana. Cost savings from improving uterotonic quality would provide financial protection and help Ghana advance toward Universal Health Coverage.
- 20 June 2024
- Published by Public Library of Science (PLoS) in PLOS Global Public Health
- Vol. 4 (6) , e0003181
Open AccessModeling the economic burden of postpartum hemorrhage due to substandard uterotonics in Ghana
Uterotonics are essential in preventing postpartum hemorrhage (PPH), the leading direct cause of maternal death worldwide. However, uterotonics are often substandard in low- and middle-income countries, contributing to poor maternal health outcomes. This study examines the health and economic impact of substandard uterotonics in Ghana. A decision-tree model was built to simulate vaginal and cesarean section births across health facilities, uterotonic quality and utilization, PPH risk and diagnosis, and resulting health and economic outcomes. We utilized delivery data from Ghana’s maternal health survey, risks of health outcomes from a Cochrane review, and E-MOTIVE trial data for health outcomes related to oxytocin quality. We compared scenarios with and without substandard uterotonics, as well as scenarios altering uterotonic use and care-seeking behaviors. We found that substandard uterotonic use contributes to $18.8 million in economic burden annually, including $6.3 million and $4.8 million in out-of-pocket expenditures in public and private sectors, respectively. Annually, the National Health Insurance Scheme bears $1.6 million in costs due to substandard uterotonic use. Substandard uterotonics contribute to $6 million in long-term productivity losses from maternal mortality annually. Improving the quality of uterotonics could reduce 20,000 (11%) PPH cases, 5,000 (11%) severe PPH cases, and 100 (11%) deaths due to PPH annually in Ghana. Ensuring the quality of uterotonics would result in millions of dollars in cost savings and improve maternal health outcomes for the government and families in Ghana. Cost savings from improving uterotonic quality would provide financial protection and help Ghana advance toward Universal Health Coverage.